HaemaLogiX was pleased to attend the prestigious International Myeloma Society (IMS) Annual Meeting & Exposition, held last week from 14 – 17 September, 2025 in Toronto, Canada.
Read article +HaemaLogiX was honoured to be awarded the “Most Promising CAR-T Pipeline in APAC” at the Asia Pacific CGT Excellence Awards 2025, held in Singapore last night.
Read article +HaemalogiX CEO Damian Clarke-Bruce presented at the 19th Bioshares Biotech Summit in Hobart, showcasing the company’s pioneering immunotherapies for multiple myeloma and B-cell disorders.
Read article +HaemaLogiX is delighted to be sharing the results of new pre-clinical data at the European Association of Hematology Congress, EHA2024, taking place this week in Madrid, Spain.
Read article +HaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg Hunt, former Federal Minister for Health, to the HaemaLogiX Board as a Non-Executive Director.
Read article +